myocardial infarction
BioMérieux Acquires Norway's SpinChip Diagnostics for €138M
The rapid spinning disk-based immunoassay technology will enhance BioMérieux's offering at the point of care, the firm said.
The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.
POC High-Sensitivity Troponin Tests Could Reduce ER Overcrowding. Is That Enough for Adoption?
Premium
Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how much difference the tests will make.
QuidelOrtho Recalls Triage Cardiac Panels Due to False Negative Results
The FDA has identified this as a Class I recall, the most serious type of recall, as use of these devices may cause serious injury or death.
QuidelOrtho Gets Canadian Approval for Point-of-Care High-Sensitivity Troponin Test
The immunoassay detects a subunit of the troponin complex released by heart muscle cells after a myocardial infarction.